Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-12

Clinical Trial Update: Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a sphenopalatine ganglion nerve block for postdural puncture headache (with cerebrospinal fluid leak) in obstetrics has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Postdural Puncture Headache, Cerebrospinal Fluid Leak | Phase 4 | Status: WITHDRAWN